Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST.

导出 LinkOut

翻译打印收藏纠错

作者： Kalevi,Kairemo ^[1] ; Eric M,Rohren ^[2] ; Pete M,Anderson ^[3] ; Gregory,Ravizzini ^[1] ; Arvind,Rao ^[4] ; Homer A,Macapinlac ^[1] ; Vivek,Subbiah ^[5]

作者单位： Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[1] Department of Radiology, Baylor College of Medicine, Houston, Texas, USA. ^[2] Ped Heme/Onc/BMT, Cleveland Clinic, Cleveland, Ohio, USA. ^[3] Department of Computational Medicine and Bioinformatics, and Radiation Oncology at University of Michigan, University of Michigan, Ann Arbor, Michigan, USA. ^[4] Department of Investigational Cancer Therapeutics, Division of Cancer Medicine and Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[5]

关键词 18F-FDG PET 223RaCl2 Imaging Na18F PET PERCIST RECIST bone scintigraphy osteosarcoma

DOI 10.1136/esmoopen-2018-000439

PMID 30962954

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

ESMO open

2019年4卷1期

e000439页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST.

ESMO open

相似文献

ESMO open

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST.

ESMO open

相似文献

ESMO open

相关期刊

检索历史清除